Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.

Yoshitaka NishikawaNobuaki HoshinoTakahiro HorimatsuTaro FunakoshiKoya HidaYoshiharu SakaiManabu MutoTakeo Nakayama

Published in: International journal of clinical oncology (2020)

Systemic chemotherapy based on fluoropyrimidine regimens was mainly used for unresectable or metastatic SBA. While it may achieve favorable outcomes with acceptable adverse effects, further evidence is needed.

Keyphrases

locally advanced
squamous cell carcinoma
small bowel
rectal cancer
small cell lung cancer
radiation therapy
type diabetes
adipose tissue
skeletal muscle
metabolic syndrome
insulin resistance
glycemic control
chemotherapy induced